IN8bio, Inc. (NASDAQ:INAB), a biotechnology firm specializing in cancer therapies, has been granted an additional 180 days to comply with Nasdaq's minimum bid price rule, as per a recent SEC filing.

New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...

Caprock Group LLC purchased a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 3,344 ...

Tonix Pharmaceuticals saw its shares swing wildly between gains and losses on Wednesday morning as they started to trade ...

Low-cost passive index investing (in the S&P 500 or Nasdaq 100) has been key to impressive results in recent years. However, ...

The week's investing action plan includes a strong dose of pharma and biotech earnings, January econ reports, plus Amazon and ...

Veganism's new-found popularity has led to a wave of new companies targeting an ever-growing market for goods free from ...

Leerink Global Healthcare Conference Date: Wednesday, March 12, 2025 Time: 10:40pm ET / 4:40pm CET Location: Miami, FL Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van ...

(NASDAQ: ETNB) couldn't quite keep pace with the broader stock market on Tuesday. Investors were hesitant to buy shares of ...

The S&P 500 advanced 0.92% to 6,067.70, with technology shares seeing the biggest gains among sectors. The Technology Select ...

Stocks rallied sharply this week, with the S&P 500 index hitting a new all-time high. One reason for the bullish sentiment was clarity about the Trump administration's initial tariff proposals, which ...

Dow Jones dragged along in the stock market today. The Nasdaq composite sank below the 20,000 level and small caps joined the ...